雜志介紹

Current Pharmaceutical Biotechnology雜志介紹

《Current Pharmaceutical Biotechnology》是一本以English為主的未開放獲取國際優(yōu)秀期刊，中文名稱當(dāng)前的制藥生物技術(shù)，本刊主要出版、報道醫(yī)學(xué)-BIOCHEMISTRY & MOLECULAR BIOLOGY領(lǐng)域的研究動態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進展，探討行業(yè)發(fā)展的思路和方法，以促進學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動作用，也得到了本專業(yè)人員的廣泛認可。該刊最新影響因子為2.2，最新CiteScore 指數(shù)為5.6。

本刊近期中國學(xué)者發(fā)表的論文主要有：

• The Role of VEGF Family in Lipid Metabolism

  Author: Zhou, Yan; Zhu, Xueping; Wang, Huan; Duan, Chenglin; Cui, Hanming; Shi, Jingjing; Shi, Shuai; Yuan, Guozhen; Hu, Yuanhui

• Distribution of Nicotinamide Mononucleotide after Intravenous Injection in Normal and Ischemic Stroke Mice

  Author: Zheng, Si-Li; Wang, Dong-Sheng; Dong, Xin; Guan, Yun-Feng; Qi, Qi; Hu, Wen-Jun; Hong, Chen; Zhang, Chuan; Miao, Chao-Yu

• Factors and Mechanisms Affecting the Secretion of Recombinant Protein in CHO Cells

  Author: Yang, Yong-Xiao; Li, Qin; Li, Wei-Dong; Wang, Tian-Yun; Feng, Hui-Gen

• Research Progress in Elucidating the Mechanisms Underlying Resveratrol Action on Lung Cancer

  Author: Xin, Rui; Shen, Biao; Huang, Zhong-Yan; Liu, Ji-Bin; Li, Sha; Jiang, Geng-Xi; Zhang, Jie; Cao, Ya-Hong; Zou, Da-Zhi; Li, Wen; Li, Chun-Guang; Ma, Yu-Shui; Fu, Da

英文介紹

Current Pharmaceutical Biotechnology雜志英文介紹

Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal includes timely in-depth reviews, original research articles and letters written by leaders in the field, covering a range of current topics in scientific areas of Pharmaceutical Biotechnology. Invited and unsolicited review articles are welcome. The journal encourages contributions describing research at the interface of drug discovery and pharmacological applications, involving in vitro investigations and pre-clinical or clinical studies. Scientific areas within the scope of the journal include pharmaceutical chemistry, biochemistry and genetics, molecular and cellular biology, and polymer and materials sciences as they relate to pharmaceutical science and biotechnology. In addition, the journal also considers comprehensive studies and research advances pertaining food chemistry with pharmaceutical implication. Areas of interest include:

DNA/protein engineering and processing

Synthetic biotechnology

Omics (genomics, proteomics, metabolomics and systems biology)

Therapeutic biotechnology (gene therapy, peptide inhibitors, enzymes)

Drug delivery and targeting

Nanobiotechnology

Molecular pharmaceutics and molecular pharmacology

Analytical biotechnology (biosensing, advanced technology for detection of bioanalytes)

Pharmacokinetics and pharmacodynamics

Applied Microbiology

Bioinformatics (computational biopharmaceutics and modeling)

Environmental biotechnology

Regenerative medicine (stem cells, tissue engineering and biomaterials)

Translational immunology (cell therapies, antibody engineering, xenotransplantation)

Industrial bioprocesses for drug production and development

Biosafety

Biotech ethics

Special Issues devoted to crucial topics, providing the latest comprehensive information on cutting-edge areas of research and technological advances, are welcome.

Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.